Globus Medical, Inc. (GMED) Reports Revenue Well Above Consensus, Brean Capital Note; PT to $33

Go back to Globus Medical, Inc. (GMED) Reports Revenue Well Above Consensus, Brean Capital Note; PT to $33

Globus Medical (GMED) Tops Q1 EPS by 2c, Raises FY Revenue Guidance

May 5, 2015 4:57 PM EDT

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.26, $0.02 better than the analyst estimate of $0.24. Revenue for the quarter came in at $131.6 million versus the consensus estimate of $122.3 million.

Globus Medical sees FY2015 EPS of $1.02, versus the consensus of $1.02. Globus Medical sees FY2015 revenue of $514... More